Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery

• मुख्य लेखकों: Theodora Katopodi (लेखक), Savvas Petanidis (लेखक), Doxakis Anestakis (लेखक), Charalampos Charalampidis (लेखक), Ioanna Chatziprodromidou (लेखक), George Floros (लेखक), Panagiotis Eskitzis (लेखक), Paul Zarogoulidis (लेखक), Charilaos Koulouris (लेखक), Christina Sevva (लेखक), Konstantinos Papadopoulos (लेखक), Marios Dagher (लेखक), Nikolaos Varsamis (लेखक), Vasiliki Theodorou (लेखक), Chrysi Maria Mystakidou (लेखक), Nikolaos Iason Katsios (लेखक), Konstantinos Farmakis (लेखक), Christoforos Kosmidis (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2023-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Following its therapeutic effect in hematological metastasis, chimeric antigen receptor (CAR) T cell therapy has gained a great deal of attention during the last years. However, the effectiveness of this treatment has been hampered by a number of challenges, including significant toxicities, difficu...